Get started
Author

Sara Carratalà‐Boscà

Observed names: Carratalá Boscá, Sara, S. Carratalá, Sara Carratala-Bosca, Sara Carratalà, Sara Carratalà Boscà, Sara Carratalà-Boscà, Sara Carratalá, Sara Carratalá Boscá, Sara Carratalá-Boscá
ORCID: 0000-0003-0021-3041
Observed ORCID: 0000-0003-0021-3041
OpenAlex ID: A5006458279
Potential Role of CHI3L1+ Astrocytes in Progression in MS
2021 · Laura Cubas-Núñez, Sara Gil-Perotín, et al. · Neurology Neuroimmunology & Neuroinflammation · 50
PDF
High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
2022 · Jéssica Castillo-Villalba, Sara Gil-Perotín, et al. · Frontiers in Immunology · 25
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study
2022 · Carmen Alcalá, Carlos Quintanilla-Bordás, et al. · Journal of Neurology · 23
Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
2022 · Carlos Quintanilla-Bordás, Francisco Gascón-Gimenez, et al. · Frontiers in Neurology · 16
PDF
Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks
2020 · Antonio Barreiro-González, Maria T. Sanz, et al. · Journal of the Neurological Sciences · 11
Design and Validation of an Expanded Disability Status Scale Model in Multiple Sclerosis
2021 · Antonio Barreiro-González, Maria T. Sanz, et al. · European Neurology · 10
Renal function’s impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis
2024 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Neurological Sciences · 8
Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype
2019 · Laura Navarro Cantó, Sara Carratalá Boscá, et al. · Frontiers in Neurology · 8
PDF
The width of the third ventricle associates with cognition and behaviour in motor neuron disease
2018 · Juan F. Vázquez-Costa, Sara Carratalà-Boscà, et al. · Acta Neurologica Scandinavica · 7
Oligoclonal M bands unveil occult inflammation in multiple sclerosis
2022 · Bonaventura Casanova, Jessica Castillo, et al. · Multiple Sclerosis and Related Disorders · 6
NFL during acute spinal cord lesions in MS: a hurdle for the detection of inflammatory activity
2022 · C. Alcalá, L. Cubas, et al. · Journal of Neurology · 6
Cross-platform analytical assessment of serum GFAP quantification in multiple sclerosis: SIMOA versus two automated immunoassays
2025 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Frontiers in Neurology · 5
PDF
Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels
2024 · Carlos Quintanilla-Bordás, Laura Cubas-Núñez, et al. · Frontiers in Neurology · 5
PDF
Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis
2022 · Carmen Alcalá Vicente, Laura Lacruz, et al. · Frontiers in Neurology · 5
PDF
Comparative Assessment of Simoa and Lumipulse for Measuring Serum Neurofilament Light Chain in Multiple Sclerosis Patients
2024 · Raquel Gasque-Rubio, Laura Cubas-Nuñez, et al. · Acta Neurologica Scandinavica · 4
PDF
Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks
2020 · Antonio Barreiro-González, Maria T. Sanz, et al. · Acta Neurologica Belgica · 3
Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study
2024 · Carlos Quintanilla-Bordás, Matías Fernández-Patón, et al. · Neurological Sciences · 2
Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?
2024 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Journal of Neuroimmunology · 2
Relapse-associated versus relapse-independent progression determines disability trajectories in multiple sclerosis beyond EDSS 3.0
2026 · Carmen Alcalá-Vicente, Jordi Tortosa-Carreres, et al. · Multiple Sclerosis and Related Disorders · 1
Is it cost-effective to request IgM oligoclonal bands against lipids in daily practice as a biomarker for poor prognosis in multiple sclerosis?
2023 · Sara Ribes García, Jessica Castillo-Villalba, et al. · Multiple Sclerosis and Related Disorders · 1
Stage-Specific Gene Expression Profiles in Multiple Sclerosis Cortical Lesions Identified via Spatial Transcriptomics
2026 · Raquel Gasque-Rubio, Laura Cubas-Nuñez, et al. · OMICS A Journal of Integrative Biology
Tear CHI3L1 in multiple sclerosis: a non-invasive biomarker linked to disease progression
2026 · Jéssica Castillo-Villalba, Raquel Gasque-Rubio, et al. · Multiple Sclerosis and Related Disorders
An algorithm to predict intrathecal IgM synthesis in multiple sclerosis patients: optimizing the use of oligoclonal band testing
2025 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
PDF
Degeneration of the Lateral Geniculate Nucleus and Optic Pathways in Association with the Practice of Boxing: A Case Report
2025 · Francisco Carlos Pérez-Miralles, Ángeles R. Bort-Martí, et al. · Neuro-Ophthalmology
Correction to: Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study
2024 · Carlos Quintanilla-Bordás, Matías Fernández-Patón, et al. · Neurological Sciences
PDF
Works count: 27
Citation count: 198
H-index: 8
I10-index: 6
Year
Topic
Type